Takeda Pharmaceutical Co. Ltd. Sponsored ADR(NYSE : TAK)
(
)
Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| LLY | Eli Lilly and Company | -0.09% | 128.20 | 1.0% | $4392.47m | |
| PFE | Pfizer Inc. | -1.18% | 41.85 | 0.9% | $1041.98m | |
| BMY | Bristol-Myers Squibb Company | -1.55% | 48.16 | 1.4% | $1005.45m | |
| JNJ | Johnson & Johnson | -0.85% | 136.93 | 0.7% | $896.15m | |
| MRK | Merck & Co., Inc. | -0.77% | 82.31 | 0.6% | $772.80m | |
| ABBV | AbbVie, Inc. | -1.83% | 79.75 | 2.2% | $482.57m | |
| AZN | AstraZeneca PLC Sponsored ADR | -0.86% | 42.58 | 1.3% | $188.71m | |
| NVS | Novartis AG Sponsored ADR | -0.26% | 93.42 | 0.2% | $172.88m | |
| GSK | GlaxoSmithKline plc Sponsored ADR | 0.05% | 41.26 | 0.2% | $87.75m | |
| NVO | Novo Nordisk A/S Sponsored ADR Class B | -1.31% | 50.71 | 0.1% | $55.62m | |
| SNY | Sanofi Sponsored ADR | -2.58% | 44.26 | 0.2% | $55.17m | |
| AKTX | Akari Therapeutics Plc Sponsored ADR | 0.99% | 4.10 | 1.6% | $21.90m | |
| LCI | Lannett Company, Inc. | -6.63% | 7.18 | 36.7% | $9.60m | |
| EPIX | ESSA Pharma Inc | -3.98% | 3.23 | 0.1% | $0.03m |
Company Profile
Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following segments: Prescription Drug, Consumer Healthcare, and Other. The Prescription Drugs segment includes the manufacture and sale of pharmaceutical products. The Consumer Healthcare segment includes the manufacture and sale of OTC drugs and quasi-drugs. The Other segment includes manufacture and sale of reagents, clinical diagnostics, and chemical products. The company was founded by Takeda Chobei on June 12, 1781 and is headquartered in Osaka, Japan.